13. INTERNATIONAL SYMPOSIUM of GASTROENTEROLOGY

  • icon-calendar Дата: 23-25/11/2023
  • icon-marker Место: Стамбу́л, Ту́рция
  • icon-user Участники: 305

Основные темы

  • Antisecretory Therapy
  • Neuro-Motility Disorders
  • Fatty Liver
  • The Liver & Metabolic Syndrome
  • Biliary Strictures Cross-Talk
  • Inflammatory Bowel Disease

Регистрационный взнос: 320 Eur, включая НДС.

В связи с большим количеством заявок на участие, в регистрации может быть отказано по техническим причинам.

ISG 2023

Для скачивания

icon-file Приглашение icon-file Программа icon-file Тезисы

Фотографии с симпозиума

Session I : Antisecretory Therapy – Challenges from Daily Practice

Anti-secretory therapy in hospital and ambulatory patients
Different countries – different approaches in a treatment of reflux disease
PPIs adverse effects – facts or fiction?
Anti-secretory therapy and microbiome
Future directions (prokinetics, H2RA, PCABs)

Session II : Neuro-motility Disorders – Revealing the Clinical Consequences

East-European consensus on management of FD
Specialistic diagnostics of motility disorders of upper GIT – where are we?
And what about DGR
When GERD overlaps with dyspepsia
Hypersensitive esophagus

Session III : Biliary stricture Cross-Talk

PSC and other precancerous conditions – are they really out of reach?
Indeterminate biliary stricture – probe, FISH or scope?
Tissue is an issue – stricture through the microscope
Cholangiocarcinoma endoscopy therapy – heating and/or stenting
Surgical Treatment of Cholangiocarcinoma: Resection vs. Transplantation
Cholangiocarcinoma oncological therapy

Session IV : Fatty Liver – Deeper Insight Into the Burden of the Issue

SLD: Easy diagnostics of liver damage, experience
Liver enzymes and metabolites elevation an important factor in fatty liver disease
Bridging NAFLD and MAFLD: Current epidemiology and future trends
Different clinical manifestations of SLD

Session V : The Liver and Metabolic Syndrome – Shed Light on the Fatty Liver Disease

Fatty liver related co-morbidities
Liver, the silent culprit behind cardiovascular mortality
Liver and insulin resistance in type 2 diabetes
Metabolic dysfunction-associated steatotic liver disase (MASLD) and hepatocellular carcinoma (HCC): clinical challenges of an intriguing link
Liver Transplantation in Metabolic Syndrome

Session VI : Inflammatory Bowel Disease – Lessons from Real World Data

Endoscopic therapy of Crohn’s disease
Gastroenterological aspects of perinatal care in IBD – from guidelines to clinical practice?
IBD care: Western vs. Eastern Europe
Small molecules in the treatment of IBD
Strategies to optimized treatment outcomes in IBD